Related references
Note: Only part of the references are listed.Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
Xiaofei Chen et al.
ACTA PHARMACEUTICA SINICA B (2021)
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
David S. Hui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Nature-derived compounds modulating Wnt/β-catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases
Gianluca Sferrazza et al.
ACTA PHARMACEUTICA SINICA B (2020)
Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19)
Leyin Zhang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
Olga Abian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Marta Menegazzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Bioactive natural compounds against human coronaviruses: a review and perspective
Yanfang Xian et al.
ACTA PHARMACEUTICA SINICA B (2020)
Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
Saleh A. Almatroodi et al.
MOLECULES (2020)
Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics
Jay A. Grobler et al.
CELL HOST & MICROBE (2020)
Roles of flavonoids against coronavirus infection
Maria Russo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
Ruocong Yang et al.
PHARMACOLOGICAL RESEARCH (2020)
The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
Dan Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
COVID-19 update: The race to therapeutic development
Julianne D. Twomey et al.
DRUG RESISTANCE UPDATES (2020)
Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro
Minsu Jang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H. M. Furtado et al.
LANCET (2020)
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
Magnus Nakrem Lyngbakken et al.
NATURE COMMUNICATIONS (2020)
Current Prevention of COVID-19: Natural Products and Herbal Medicine
Junqing Huang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
Jie Fang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
Daniel E. Leisman et al.
LANCET RESPIRATORY MEDICINE (2020)
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
Yuezhou Chen et al.
CELL (2020)
The tea catechin epigallocatechin gallate inhibits NF-κB-mediated transcriptional activation by covalent modification
Sowmya P. Lakshmi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Alexandra C. Walls et al.
CELL (2020)
Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry
Peng Xu et al.
EMERGING MICROBES & INFECTIONS (2020)
Ultra-large library docking for discovering new chemotypes
Jiankun Lyu et al.
NATURE (2019)
Protective effect of green tea catechin against urban fine dust particle-induced skin aging by regulation of NF-κB, AP-1, and MAPKs signaling pathways
Lei Wang et al.
ENVIRONMENTAL POLLUTION (2019)
Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols
Lujuan Xing et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review
Muhammad Akram et al.
PHYTOTHERAPY RESEARCH (2018)
Antiviral potential of natural compounds against influenza virus hemagglutinin
S. Kannan et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2017)
The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
Yuewen Ding et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Effective inhibition of MERS-CoV infection by resveratrol
Shih-Chao Lin et al.
BMC INFECTIOUS DISEASES (2017)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Looking for protein stabilizing drugs with thermal shift assay
Giuseppina Andreotti et al.
DRUG TESTING AND ANALYSIS (2015)
Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Liang Dong et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Direct interaction of natural and synthetic catechins with signal transducer activator of transcription 1 affects both its phosphorylation and activity
Marta Menegazzi et al.
FEBS JOURNAL (2014)
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Rolf Hilgenfeld
FEBS JOURNAL (2014)
The newly emerged SARS-Like coronavirus HCoV-EMC also has an Achilles' heel: current effective inhibitor targeting a 3C-like protease
Zhilin Ren et al.
PROTEIN & CELL (2013)
Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
Thi Thanh Hanh Nguyen et al.
BIOTECHNOLOGY LETTERS (2012)
Activation and maturation of SARS-CoV main protease
Bin Xia et al.
PROTEIN & CELL (2011)
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
Young Bae Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design
Xiaoyu Xue et al.
JOURNAL OF VIROLOGY (2008)
Binding interaction of quereetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro:: Structure-activity relationship studies reveal salient pharmacophore features
Lili Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Design of wide-spectrum inhibitors targeting coronavirus main proteases
HT Yang et al.
PLOS BIOLOGY (2005)
Antiviral activity of glycyrrhizic acid derivatives against SARS - Coronavirus
G Hoever et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
J Cinatl et al.
LANCET (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Share Paper
